American Century Companies Inc Ascendis Pharma A/S Transaction History

American Century Companies Inc

$188 Billion
Q3 2025

A detailed history of American Century Companies Inc transactions in Ascendis Pharma A/S stock. As of the latest transaction made, American Century Companies Inc holds 544,606 shares of ASND stock, worth $111 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares

544,606

Previous 530,809 2.6%

Holding current value

$111 Million

Previous $91.6 Million 18.18%

% of portfolio

0.06%

Previous 0.05%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 12, 2025	BUY	$163.32 - $205.91 $2.25 Million - $2.84 Million	13,797 Added 2.6%	544,606 $108 Million
Q2 2025 Aug 12, 2025	BUY	$137.41 - $179.1 $9.43 Million - $12.3 Million	68,638 Added 14.85%	530,809 $91.6 Million
Q1 2025 May 13, 2025	BUY	$119.49 - $168.84 $6.56 Million - $9.27 Million	54,877 Added 13.47%	462,171 $72 Million
Q4 2024 Feb 11, 2025	BUY	$122.0 - $146.6 $7.39 Million - $8.88 Million	60,548 Added 17.46%	407,294 $56.1 Million
Q3 2024 Nov 12, 2024	BUY	$113.0 - $153.43 $4.61 Million - $6.26 Million	40,772 Added 13.33%	346,746 $51.8 Million

Q2 2024 Aug 07, 2024	SELL	$121.07 - $153.67 $20,218 - $25,662	-167 Reduced 0.05%	305,974 $41.7 Million
Q1 2024 May 14, 2024	SELL	$123.45 - $159.4 $197,026 - $254,402	-1,596 Reduced 0.52%	306,141 $46.3 Million
Q4 2023 Feb 13, 2024	BUY	$86.1 - $127.36 $26.5 Million - $39.2 Million	307,737 New	307,737 $38.8 Million
Q3 2023 Nov 13, 2023	SELL	$86.5 - $103.97 $2.86 Million - $3.44 Million	-33,092 Reduced 9.13%	329,274 $30.8 Million
Q2 2023 Aug 14, 2023	BUY	$69.96 - $97.84 $400,800 - $560,525	5,729 Added 1.61%	362,366 $32.3 Million
Q1 2023 May 11, 2023	BUY	$104.9 - $126.78 $1.36 Million - $1.64 Million	12,943 Added 3.77%	356,637 $38.2 Million
Q4 2022 Feb 13, 2023	BUY	$99.42 - $131.97 $108,765 - $144,375	1,094 Added 0.32%	343,694 $42 Million
Q3 2022 Nov 14, 2022	BUY	$84.03 - $110.23 $177,639 - $233,026	2,114 Added 0.62%	342,600 $35.4 Million
Q2 2022 Aug 12, 2022	SELL	$78.08 - $117.61 $965,068 - $1.45 Million	-12,360 Reduced 3.5%	340,486 $31.7 Million
Q1 2022 May 11, 2022	BUY	$102.18 - $135.75 $3.13 Million - $4.16 Million	30,648 Added 9.51%	352,846 $41.4 Million
Q4 2021 Feb 07, 2022	BUY	$127.1 - $169.66 $5.83 Million - $7.78 Million	45,865 Added 16.6%	322,198 $43.3 Million
Q3 2021 Nov 10, 2021	BUY	$112.67 - $176.92 $1.83 Million - $2.87 Million	16,230 Added 6.24%	276,333 $44 Million
Q2 2021 Aug 05, 2021	BUY	$121.62 - $145.29 $7.38 Million - $8.82 Million	60,720 Added 30.45%	260,103 $34.2 Million
Q1 2021 May 14, 2021	BUY	$124.92 - $173.33 $24.9 Million - $34.6 Million	199,383 New	199,383 $25.7 Million

Others Institutions Holding ASND

# of Institutions

318

Shares Held

65M

Call Options Held

476K

Put Options Held

142K

View Full List

About Ascendis Pharma A/S

Ticker ASND
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,810,200
Market Cap $11.4B
Description
Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapeutics for unmet medical needs. The company offers SKYTROFA for treating patients with growth hormone deficiency (GHD). It also develops TransCon Growth Hormone (hGH) for pediatric GHD in Japan; TransCon hGH for adults with GHD; TransCon parathyroid hormone for adult h...

More about ASND

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of American Century Companies Inc, based on Form 13F filings with the SEC.

News

Stay updated on American Century Companies Inc with notifications on news.

Account

American Century Companies Inc Ascendis Pharma A/S Transaction History